<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37531658</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6613</ISSN><JournalIssue CitedMedium="Internet"><Volume>229</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>14</Day></PubDate></JournalIssue><Title>The Journal of infectious diseases</Title><ISOAbbreviation>J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Risk of Subsequent Respiratory Virus Detection After Primary Virus Detection in a Community Household Study-King County, Washington, 2019-2021.</ArticleTitle><Pagination><StartPage>422</StartPage><EndPage>431</EndPage><MedlinePgn>422-431</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/infdis/jiad305</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The epidemiology of respiratory viral infections is complex. How infection with one respiratory virus affects risk of subsequent infection with the same or another respiratory virus is not well described.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From October 2019 to June 2021, enrolled households completed active surveillance for acute respiratory illness (ARI), and participants with ARI self-collected nasal swab specimens; after April 2020, participants with ARI or laboratory-confirmed severe acute respiratory syndrome coronavirus 2 and their household members self-collected nasal swab specimens. Specimens were tested using multiplex reverse-transcription polymerase chain reaction for respiratory viruses. A Cox regression model with a time-dependent covariate examined risk of subsequent detections following a specific primary viral detection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Rhinovirus was the most frequently detected pathogen in study specimens (406 [9.5%]). Among 51 participants with multiple viral detections, rhinovirus to seasonal coronavirus (8 [14.8%]) was the most common viral detection pairing. Relative to no primary detection, there was a 1.03-2.06-fold increase in risk of subsequent virus detection in the 90 days after primary detection; risk varied by primary virus: human parainfluenza virus, rhinovirus, and respiratory syncytial virus were statistically significant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Primary virus detection was associated with higher risk of subsequent virus detection within the first 90 days after primary detection.</AbstractText><CopyrightInformation>Â© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heimonen</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5737-7456</Identifier><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Eric J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-3349-9330</Identifier><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prevention Division, Public Health-Seattle &amp; King County, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yongzhe</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hughes</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biostatistics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogers</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Emanuels</LastName><ForeName>Anne</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3876-1895</Identifier><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Hanlon</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Peter D</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolf</LastName><ForeName>Caitlin R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Logue</LastName><ForeName>Jennifer K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogokeh</LastName><ForeName>Constance E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Military and Health Research Foundation, Laurel, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolfes</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uyeki</LastName><ForeName>Timothy M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starita</LastName><ForeName>Lea</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2870-5099</Identifier><AffiliationInfo><Affiliation>Brotman Baty Institute for Precision Medicine, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genome Sciences, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Englund</LastName><ForeName>Janet A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Pediatric Infectious Diseases, Seattle Children's Research Institute, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Helen Y</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002319</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Infect Dis</MedlineTA><NlmUniqueID>0413675</NlmUniqueID><ISSNLinking>0022-1899</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014861" MajorTopicYN="N" Type="Geographic">Washington</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014780" MajorTopicYN="Y">Viruses</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018113" MajorTopicYN="Y">Respiratory Syncytial Virus, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coinfection</Keyword><Keyword MajorTopicYN="N">household transmission</Keyword><Keyword MajorTopicYN="N">respiratory viral infection</Keyword><Keyword MajorTopicYN="N">seasonal epidemic</Keyword><Keyword MajorTopicYN="N">viral interference</Keyword></KeywordList><CoiStatement>Potential conflicts of interest . E. J. C. received honoraria from Providence Regional Medical Center in Everett, Washington, for presentations on coronavirus disease 2019 and received a travel award from the Infectious Diseases Society of America to attend IDWeek 2022. J. A. E. reports consulting with AstraZeneca, Meissa Vaccines, and Sanofi Pasteur, as well as research support from AstraZeneca, GlaxoSmithKline, Merck, and Pfizer. H. Y. C. reports consulting with Ellume, Pfizer, the Bill and Melinda Gates Foundation, Glaxo Smith Kline, and Merck. She has received research funding from Gates Ventures and Sanofi Pasteur and support and reagents from Ellume and Cepheid, outside the submitted work. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>2</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37531658</ArticleId><ArticleId IdType="pmc">PMC10873185</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiad305</ArticleId><ArticleId IdType="pii">7235955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Iuliano AD, Roguski KM, Chang HH, et al. . Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391:1285â300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5935243</ArticleId><ArticleId IdType="pubmed">29248255</ArticleId></ArticleIdList></Reference><Reference><Citation>Rha B, Curns AT, Lively JY, et al. . Respiratory syncytial virus-associated hospitalizations among young children: 2015â2016. Pediatrics 2020; 146:e20193611.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546583</ArticleId></ArticleIdList></Reference><Reference><Citation>Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med 2005; 352:1749â59.</Citation><ArticleIdList><ArticleId IdType="pubmed">15858184</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med 2003; 163:487â94.</Citation><ArticleIdList><ArticleId IdType="pubmed">12588210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee N, Smith S, Zelyas N, et al. . Burden of noninfluenza respiratory viral infections in adults admitted to hospital: analysis of a multiyear Canadian surveillance cohort from 2 centres. CMAJ 2021; 193:E439âE46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099164</ArticleId><ArticleId IdType="pubmed">33782171</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol 2022; 21:195â210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9574826</ArticleId><ArticleId IdType="pubmed">36253478</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A, Mihaylova VT, Landry ML, Foxman EF. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study. Lancet Microbe 2020; 1:e254âe62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7580833</ArticleId><ArticleId IdType="pubmed">33103132</ArticleId></ArticleIdList></Reference><Reference><Citation>Piret J, Boivin G. Viral interference between respiratory viruses. Emerg Infect Dis 2022; 28:273â81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798701</ArticleId><ArticleId IdType="pubmed">35075991</ArticleId></ArticleIdList></Reference><Reference><Citation>Casalegno JS, Ottmann M, Duchamp MB, et al. . Rhinoviruses delayed the circulation of the pandemic influenza A (H1N1) 2009 virus in France. Clin Microbiol Infect 2010; 16:326â9.</Citation><ArticleIdList><ArticleId IdType="pubmed">20121829</ArticleId></ArticleIdList></Reference><Reference><Citation>Linde A, Rotzen-Ostlund M, Zweygberg-Wirgart B, Rubinova S, Brytting M. Does viral interference affect spread of influenza? Euro Surveill 2009; 14:19354.</Citation><ArticleIdList><ArticleId IdType="pubmed">19822124</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuse Y, Tamaki R, Okamoto M, et al. . Association between preceding viral respiratory infection and subsequent respiratory illnesses among children: a prospective cohort study in the Philippines. J Infect Dis 2019; 219:197â205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6306022</ArticleId><ArticleId IdType="pubmed">30189092</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard LM, Liu Y, Zhu Y, et al. . Assessing the impact of acute respiratory illnesses on the risk of subsequent respiratory illness. J Infect Dis 2022; 225:42â9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8730497</ArticleId><ArticleId IdType="pubmed">34120189</ArticleId></ArticleIdList></Reference><Reference><Citation>Emanuels A, Heimonen J, O'Hanlon J, et al. . Remote household observation for non-influenza respiratory viral illness. Clin Infect Dis 2021; 73:e4411â18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7717193</ArticleId><ArticleId IdType="pubmed">33197930</ArticleId></ArticleIdList></Reference><Reference><Citation>
State of Washington: Office of the Governor. 
Proclamation by the Governor amending proclamation 20â05: Stay HomeâStay Healthy.
https://www.governor.wa.gov/sites/default/files/proclamations/20%â25%20Coronovirus%20Stay%20Safe-Stay%20Healthy%20%28tmp%29%20%28002%29.pdf
. Accessed 27 January 2022.</Citation></Reference><Reference><Citation>Heimonen J, McCulloch DJ, O'Hanlon J, et al. . A remote household-based approach to influenza self-testing and antiviral treatment. Influenza Other Respir Viruses 2021; 15:469â77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189204</ArticleId><ArticleId IdType="pubmed">33939275</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim AE, Brandstetter E, Wilcox N, et al. . Evaluating specimen quality and results from a community-wide, home-based respiratory surveillance study. J Clin Microbiol 2021; 59:e02934-20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8091861</ArticleId><ArticleId IdType="pubmed">33563599</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)âa metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377â81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Weil AA, Sohlberg SL, O'Hanlon JA, et al. . SARS-CoV-2 epidemiology on a public university campus in Washington state. Open Forum Infect Dis 2021; 8:ofab464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8599730</ArticleId><ArticleId IdType="pubmed">34805425</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Washington.  [. Accessed 27 January.]. http://depts.washington.edu/uwviro/wp-content/uploads/2020/07/VD2019-20-updated-through-07.04.2020.pdf 2019â2020 Respiratory &amp; enteric viruses: Seattle, Washington.</Citation></Reference><Reference><Citation>University of Washington.  [. Accessed 27bJanuary.]. http://depts.washington.edu/uwviro/wp-content/uploads/2021/09/VD2020-21-updated-through-09.04.2021.pdf 2020â2021 Respiratory &amp; enteric viruses: Seattle, Washington.</Citation></Reference><Reference><Citation>Nickbakhsh S, Mair C, Matthews L, et al. . Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A 2019; 116:27142â50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6936719</ArticleId><ArticleId IdType="pubmed">31843887</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KF, Carolan LA, Korenkov D, et al. . Investigating viral interference between influenza A virus and human respiratory syncytial virus in a ferret model of infection. J Infect Dis 2018; 218:406â17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107400</ArticleId><ArticleId IdType="pubmed">29746640</ArticleId></ArticleIdList></Reference><Reference><Citation>Achten NB, Wu P, Bont L, et al. . Interference between respiratory syncytial virus and human rhinovirus infection in infancy. J Infect Dis 2017; 215:1102â6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5426371</ArticleId><ArticleId IdType="pubmed">28368456</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox JP, Hall CE, Cooney MK, Luce RE, Kronmal RA. The Seattle virus watch. II. Objectives, study population and its observation, data processing and summary of illnesses. Am J Epidemiol 1972; 96:270â85.</Citation><ArticleIdList><ArticleId IdType="pubmed">5074683</ArticleId></ArticleIdList></Reference><Reference><Citation>Elveback LR, Fox JP, Ketler A, Brandt CD, Wassermann FE, Hall CE. The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. 3. Preliminary report on association of infections with disease. Am J Epidemiol 1966; 83:436â54.</Citation><ArticleIdList><ArticleId IdType="pubmed">4286697</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto AS, Napier JA, Metzner HL. The Tecumseh study of respiratory illness. I. Plan of study and observations on syndromes of acute respiratory disease. Am J Epidemiol 1971; 94:269â79.</Citation><ArticleIdList><ArticleId IdType="pubmed">5093655</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJonge PM, Monto AS, Malosh RE, et al. . Distinct influenza surveillance networks and their agreement in recording regional influenza circulation: experience from southeast Michigan. Influenza Other Respir Viruses 2022; 16: 521â31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8983886</ArticleId><ArticleId IdType="pubmed">34821476</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto AS, Malosh RE, Petrie JG, Thompson MG, Ohmit SE. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. J Infect Dis 2014; 210:1792â9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4296188</ArticleId><ArticleId IdType="pubmed">24907381</ArticleId></ArticleIdList></Reference><Reference><Citation>Budge PJ, Griffin MR, Edwards KM, et al. . A household-based study of acute viral respiratory illnesses in Andean children. Pediatr Infect Dis J 2014; 33:443â7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4223552</ArticleId><ArticleId IdType="pubmed">24378948</ArticleId></ArticleIdList></Reference><Reference><Citation>Takashita E, Kawakami C, Momoki T, et al. . Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses 2021; 15:488â94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189209</ArticleId><ArticleId IdType="pubmed">33715290</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuitunen I, Artama M, Haapanen M, Renko M. Rhinovirus spread in children during the COVID-19 pandemic despite social restrictionsâa nationwide register study in Finland. J Med Virol 2021; 93:6063â7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426983</ArticleId><ArticleId IdType="pubmed">34228369</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Glass E, Hoang VT, Boschi C, et al. . Incidence and outcome of coinfections with SARS-CoV-2 and rhinovirus. Viruses 2021; 13:2528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8709236</ArticleId><ArticleId IdType="pubmed">34960797</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>